• 1
    Lai, Y. and Gallo, R. L., AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009. 30: 131141.
  • 2
    Hollox, E. J., Armour, J. A. and Barber, J. C., Extensive normal copy number variation of a beta-defensin antimicrobial-gene cluster. Am. J. Hum. Genet. 2003. 73: 591600.
  • 3
    Hollox, E. J., Huffmeier, U., Zeeuwen, P. L., Palla, R., Lascorz, J., Rodijk-Olthuis, D., van de Kerkhof, P. C. et al., Psoriasis is associated with increased beta-defensin genomic copy number. Nat. Genet. 2008. 40: 2325.
  • 4
    Fellermann, K., Stange, D. E., Schaeffeler, E., Schmalzl, H., Wehkamp, J., Bevins, C. L., Reinisch, W. et al., A chromosome 8 gene-cluster polymorphism with low human beta-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J.Hum. Genet. 2006. 79: 439448.
  • 5
    Harder, J., Bartels, J., Christophers, E. and Schroder, J. M., Isolation and characterization of human beta -defensin-3, a novel human inducible peptide antibiotic. J. Biol. Chem. 2001. 276: 57075713.
  • 6
    Gambichler, T., Skrygan, M., Tomi, N. S., Othlinghaus, N., Brockmeyer, N. H., Altmeyer, P. and Kreuter, A., Differential mRNA expression of antimicrobial peptides and proteins in atopic dermatitis as compared to psoriasis vulgaris and healthy skin. Int. Arch. Allergy Immunol. 2008. 147: 1724.
  • 7
    Semple, C. A., Rolfe, M. and Dorin, J. R., Duplication and selection in the evolution of primate beta-defensin genes. Genome Biol. 2003. 4: R31.
  • 8
    Garcia, J. R., Jaumann, F., Schulz, S., Krause,A., Rodriguez-Jimenez, J., Forssmann, U., Adermann, K. et al., Identification of a novel, multifunctional beta-defensin (human beta- defensin 3) with specific antimicrobial activity. Its interaction with plasma membranes of Xenopus oocytes and the induction of macrophage chemoattraction. Cell Tissue Res. 2001. 306: 257264.
  • 9
    Jia, H. P., Schutte, B. C., Schudy, A., Linzmeier, R., Guthmiller, J. M., Johnson, G. K., Tack, B. F. et al., Discovery of new human beta-defensins using a genomics-based approach. Gene 2001. 263: 211218.
  • 10
    Yang, D., Chertov, O., Bykovskaia, S. N., Chen, Q., Buffo, M. J., Shogan, J., Anderson, M. et al., Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999. 286: 525528.
  • 11
    Garcia, J. R., Krause, A., Schulz, S., Rodriguez-Jimenez, F. J., Kluver, E., Adermann, K., Forssmann, U. et al., Human beta-defensin 4: a novel inducible peptide with a specific salt- sensitive spectrum of antimicrobial activity. FASEB J. 2001. 15: 18191821.
  • 12
    Funderburg, N., Lederman, M. M., Feng, Z., Drage, M. G., Jadlowsky, J., Harding, C. V., Weinberg, A. and Sieg, S. F., Human -defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2. Proc. Natl. Acad. Sci. USA 2007. 104: 1863118635.
  • 13
    Miles, K., Clarke, D. J., Lu, W., Sibinska, Z., Beaumont, P. E., Davidson, D. J., Barr, T. A. et al., Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensins. J. Immunol. 2009. 183: 21222132.
  • 14
    Candille, S. I., Kaelin, C. B., Cattanach, B. M., Yu, B., Thompson, D. A., Nix, M. A., Kerns, J. A. et al., A beta-Defensin mutation causes black coat color in domestic dogs. Science 2007. 318: 14181423.
  • 15
    Anderson, T. M., von Holdt, B. M., Candille, S. I., Musiani, M., Greco, C., Stahler, D. R., Smith, D. W. et al., Molecular and evolutionary history of melanism in North American gray wolves. Science 2009. 323: 13391343.
  • 16
    Mookherjee, N., Brown, K. L., Bowdish, D. M., Doria, S., Falsafi, R., Hokamp, K., Roche, F. M. et al., Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37. J. Immunol. 2006. 176: 24552464.
  • 17
    Di Nardo, A., Braff, M. H., Taylor, K. R., Na, C., Granstein, R. D., McInturff, J. E., Krutzik, S. et al., Cathelicidin antimicrobial peptides block dendritic cell TLR4 activation and allergic contact sensitization. J. Immunol. 2007. 178: 18291834.
  • 18
    Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D. and Hancock, R. E., The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses. J. Immunol. 2002. 169: 38833891.
  • 19
    Semple, C. A., Maxwell, A., Gautier, P., Kilanowski, F. M., Eastwood, H., Barran, P. E. and Dorin, J. R., The complexity of selection at the major primate beta-defensin locus. BMC Evol. Biol. 2005. 5: 32.
  • 20
    Taylor, K., Clarke, D. J., McCullough, B., Chin, W., Seo, E., Yang, D., Oppenheim, J. et al., Analysis and separation of residues important for the chemoattractant and antimicrobial activities of beta -defensin 3. J. Biol. Chem. 2008. 283: 66316639.
  • 21
    Molhoek, E. M., den Hertog, A. L., de Vries, A. M., Nazmi, K., Veerman, E. C., Hartgers, F. C., Yazdanbakhsh, M. et al., Structure-function relationship of the human antimicrobial peptide LL-37 and LL-37 fragments in the modulation of TLR responses. Biol. Chem. 2009. 390: 295303.
  • 22
    Motzkus, D., Schulz-Maronde, S., Heitland, A., Schulz, A., Forssmann, W. G., Jubner, M. and Maronde, E., The novel beta-defensin DEFB123 prevents lipopolysaccharide-mediated effects in vitro and in vivo. FASEB J. 2006. 20: 17011702.
  • 23
    Howard, M., Muchamuel, T., Andrade, S. and Menon, S., Interleukin 10 protects mice from lethal endotoxemia. J. Exp. Med. 1993. 177: 12051208.
  • 24
    Wu, Z., Hoover, D. M., Yang, D., Boulegue, C., Santamaria, F., Oppenheim, J. J., Lubkowski, J. and Lu, W., Engineering disulfide bridges to dissect antimicrobial and chemotactic activities of human beta-defensin 3. Proc. Natl. Acad. Sci. USA 2003. 100: 88808885.
  • 25
    Catania, A., Gatti, S., Colombo, G., and Lipton, J. M., Targeting melanocortin receptors as a novel strategy to control inflammation. Pharmacol. Rev. 2004. 56: 129.
  • 26
    Li, D. and Taylor, A. W., Diminishment of alpha-MSH anti-inflammatory activity in MC1r siRNA-transfected RAW264.7 macrophages. J. Leukoc. Biol. 2008. 84: 191198.
  • 27
    Getting, S. J., Lam, C. W., Chen, A. S., Grieco, P. and Perretti, M., Melanocortin 3 receptors control crystal-induced inflammation. FASEB J. 2006. 20: 22342241.
  • 28
    Robbins, L. S., Nadeau, J. H., Johnson, K. R., Kelly, M. A., Roselli-Rehfuss, L., Baack, E., Mountjoy, K. G., and Cone, R. D., Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell 1993. 72: 827834.
  • 29
    Chen, A. S., Marsh, D. J., Trumbauer, M. E., Frazier, E. G., Guan, X. M., Yu, H., Rosenblum, C. I. et al., Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass. Nat. Genet. 2000. 26: 97102.
  • 30
    Moore, K. W., de Waal, M. R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683765.
  • 31
    Peters-Golden, M., Putting on the brakes: cyclic AMP as a multipronged controller of macrophage function. Sci. Signal. 2009. 2: e37.
  • 32
    Chino, N., Kubo, S., Nishio, H., Nishiuchi, Y., Nakazato, M. and Kimura, T., Chemical synthesis of human beta defenin (hBD) -1,-2,-3,-4. Optimisation of the oxidative folding reaction. Int. J. Peptide Res. Therapeutics 2006. 12: 203209.
  • 33
    Barlow, P. G., Li, Y., Wilkinson, T. S., Bowdish, D. M., Lau, Y. E., Cosseau, C., Haslett, C. et al., The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system. J. Leukoc. Biol. 2006. 80: 509520.